Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
Abroad (travel likely)RecruitingPHASE1
Conditions
Myelodysplastic Syndromes · Chronic Myelomonocytic Leukemia · Acute Myeloid Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Prince of Wales Hospital, Sydney, New South Wales, Australia
Contact: Study coordinator (Mark Hertzberg, Dr)Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Contact: Study coordinator (Stephen Larsen Dr)Concord Repatriation and General Hospital, Sydney, New South Wales, Australia
Contact: Study coordinator (Robin Gasiorowski Dr)Nepean Hospital, Sydney, New South Wales, Australia
Contact: Study coordinator (Stephen Fuller Dr)Westmead Hospital, Westmead, New South Wales, Australia
Contact: Study coordinator (Lachlin Vaughan DR)
Study leads
John Pimanda, Professor
Principal Investigator
University of New South Wales